Among others, the most described predictors are: chronic dysfunction [38, 42, 46], episodes of acute rejection [3, 38–41], death with functional graft [38, 46], glomerulonephritis [38], donor age [47], hypertension [47, 48], diabetes [41, 47], type of immunosuppression [47], delayed graft function [47], recipient age [3], race [3], albumin [3], proteinuria [3, 42, 47], low-density lipoprotein (LDL) cholesterol levels [48] and higher BMI [49]. This evidence concerns the gene ALB and glomerulonephritis.